ArticleFrontiers in neurology2025
Clinical and hemodynamic outcomes of side-to-side anastomosis in superficial temporal artery-middle cerebral artery bypass for adult patients with moyamoya disease: a prospective cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Semi-Quantitative Assessment of Regional Cerebral Blood Flow Changes Following Extracranial-Intracranial Bypass Using SPECT: A Single-Center Retrospective Study.Journal of clinical medicine · 2026Article
- Side-to-Side versus Traditional End-to-Side Approach to STA-MCA Bypass in Moyamoya Disease: A Comparative Meta-analysis.Journal of neurological surgery reports · 2026Article
- Postoperative perfusion volume on territorial arterial spin labeling provides an exploratory risk signal for cerebrovascular autoregulation failure after moyamoya revascularization: a prospective physiological study.Frontiers in physiology · 2026Article
- Preoperative local hemodynamics predict cerebral hyperperfusion syndrome after direct bypass for moyamoya disease: a quantitative CTP study based on ASPECT topography.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Superficial temporal artery-middle cerebral artery (STA-MCA) bypass, characterized by side-to-side (S-S) anastomosis, has been beneficial in reducing the incidence of postoperative complications and recurrent stroke in patients with moyamoya disease (MMD). However, the safety and efficacy of this unconventional S-S procedure remain unclear. This research aimed to investigate the clinical and hemodynamic outcomes associated with the S-S technique. Methods: Clinical and radiographic data were collected from 50 adult patients with MMD (50 hemispheres), including 23 cases treated with S-S anastomosis and 27 cases treated with end-to-side (E-S) STA-MCA bypass. The patients' demographic information, clinical presentation, associated medical conditions, intraoperative hemodynamics, postoperative hemispheric perfusion status, and clinical course were obtained through a review of medical records, intraoperative microvascular Doppler ultrasonography (MDU), and postoperative CT perfusion (CTP) imaging. Results: There was no significant difference between the S-S and E-S groups in baseline characteristics, postoperative complications, bypass patency rate, neovascularization, and modified Rankin Scale (mRS) scores ( Conclusion: The S-S technique demonstrated a different intraoperative self-flow regulation capacity compared to the traditional E-S technique, but it showed no superiority in postoperative hemispheric perfusion and clinical outcomes. The choice of bypass procedure should be individualized.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.